ASTRAZENECA PHARMA INDIA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of AstraZeneca Pharma India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
3.09₹ 268.15
As on Feb 10, 2026, 4:01 PM IST
AstraZeneca Pharma India Price Performance
Today's LowToday's High
₹8,726.60₹8,990.00
₹8,944.00
52 Weeks' Low52 Weeks' High
₹6,501.60₹10,653.05
₹8,944.00
Open Price
₹8,874.15
Prev. Close
₹8,675.85
Volume
825
Over the last 5 years, the share price of AstraZeneca Pharma India has gained 19.28% CAGR. Over the past year, the corresponding return has been 18.70%.
AstraZeneca Pharma India’s current P/E of 112.28x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
AstraZeneca Pharma India Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharma India | 2.84 | 8.78 | -1.57 | 1.74 | 18.70 | 38.36 | 19.28 |
| Sun Pharmaceutical Industries | 0.28 | -1.69 | 0.59 | 5.89 | -1.44 | 19.26 | 22.18 |
| Divi's Laboratories | -0.87 | -5.14 | -8.03 | 2.78 | 3.78 | 29.86 | 10.42 |
| Torrent Pharmaceuticals | 0.68 | 3.18 | 6.71 | 12.73 | 27.68 | 38.81 | 25.80 |
| Cipla | 1.49 | -8.45 | -11.34 | -10.73 | -7.97 | 9.12 | 9.22 |
| Dr. Reddy's Laboratories | 1.79 | 3.41 | 4.90 | 3.11 | 2.97 | 11.80 | 5.45 |
| Lupin | 0.73 | 0.58 | 10.82 | 13.16 | 1.50 | 44.02 | 15.56 |
| Zydus Lifesciences | -1.77 | -0.89 | -6.34 | -7.17 | -8.03 | 23.31 | 13.62 |
| Mankind Pharma | -3.76 | -6.83 | -7.22 | -14.85 | -17.25 | 13.37 | 7.82 |
| Alkem Laboratories | 1.72 | -1.14 | 2.15 | 19.81 | 20.84 | 20.71 | 15.00 |
| Aurobindo Pharma | -8.47 | -4.29 | -2.66 | 6.61 | -4.63 | 33.78 | 3.01 |
| Biocon | -0.55 | -0.50 | -3.15 | 8.23 | -1.86 | 15.15 | -1.93 |
| Abbott India | 1.86 | -3.67 | -7.21 | -17.06 | -7.73 | 9.68 | 13.75 |
| Glenmark Pharmaceuticals | 0.02 | -3.07 | 6.74 | -4.48 | 29.23 | 69.76 | 30.98 |
| Laurus Labs | -0.91 | -7.22 | -3.44 | 16.32 | 54.60 | 41.65 | 21.91 |
| GlaxoSmithKline Pharmaceuticals | 7.18 | 8.81 | 2.74 | -2.91 | 21.87 | 27.76 | 12.55 |
| Anthem Biosciences | 11.52 | 9.63 | -3.96 | -10.16 | -7.29 | -2.49 | -1.50 |
| Ipca Laboratories | -0.26 | -6.44 | 6.26 | 6.93 | -1.11 | 17.82 | 7.74 |
| Ajanta Pharma | 0.19 | 5.51 | 14.13 | 8.95 | 11.01 | 33.69 | 19.26 |
| Gland Pharma | -0.22 | 10.96 | 0.45 | -2.40 | 27.78 | 12.92 | -3.85 |
Over the last one year, AstraZeneca Pharma India has gained 18.70% compared to peers like Sun Pharmaceutical Industries (-1.44%), Divi's Laboratories (3.78%), Torrent Pharmaceuticals (27.68%). From a 5 year perspective, AstraZeneca Pharma India has outperformed peers relative to Sun Pharmaceutical Industries (22.18%) and Divi's Laboratories (10.42%).
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 8,636.01 | 8,604.89 |
| 10 | 8,550.88 | 8,557.77 |
| 20 | 8,412.55 | 8,536.94 |
| 50 | 8,739.01 | 8,679.51 |
| 100 | 8,955.76 | 8,788.91 |
| 200 | 8,897.47 | 8,632.84 |
AstraZeneca Pharma India Share Holding Pattern
In the latest quarter, AstraZeneca Pharma India remained same as its previous close in promoter holding, while DII stake increased to 5.55%, FII holding fell to 2.71%, and public shareholding moved down to 16.73% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
AstraZeneca Pharma India Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 6,58,075 | 0.87 | 594.18 | |
| 1,10,637 | 0.73 | 99.89 | |
| 83,964 | 3.82 | 75.81 | |
| 62,568 | 0.68 | 56.49 | |
| 55,021 | 0.77 | 49.68 | |
| 32,200 | 2.38 | 29.07 | |
| 30,600 | 2.85 | 27.63 | |
| 22,090 | 0.12 | 19.95 | |
| 20,044 | 1.15 | 18.1 | |
| 18,870 | 0.2 | 17.04 |
* Excluding Index & Arbitrage Funds
AstraZeneca Pharma India Corporate Actions
Date Time | Announcement |
|---|---|
| Feb 10, 2026, 4:23 PM IST | AstraZeneca Pharma I - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2 |
| Jan 31, 2026, 7:12 PM IST | AstraZeneca Pharma I - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2 |
| Jan 31, 2026, 7:08 PM IST | AstraZeneca Pharma I - Board Meeting Intimation for Considering And Approval Of The Unaudited Financial Results Of The Compan |
| Jan 29, 2026, 10:32 PM IST | AstraZeneca Pharma I - Announcement under Regulation 30 (LODR)-Resignation of Director |
| Jan 17, 2026, 12:25 AM IST | AstraZeneca Pharma I - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
About AstraZeneca Pharma India
AstraZeneca Pharma India Ltd. is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1716.29 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressBlock N1, 12th Floor, Bengaluru Karnataka 560045
- Contact
Management
- Ms. Shilpa Divekar NirulaChairperson & Independent Director
- Mr. Praveen Rao AkkinepallyManaging Director
- Ms. Bhavana AgrawalExecutive Director
- Ms. Sylvia Lorena Varela RamonNon Executive Director
- Ms. Hooi Bien ChuahNon Executive Director
- Mr. Jesus Javier Diaz-Ropero EstesoNon Executive Director
- Ms. Revathy AshokIndependent Director
- Ms. Monica WidhaniIndependent Director
FAQs on AstraZeneca Pharma India Share Price
What is the share price of AstraZeneca Pharma India?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for AstraZeneca Pharma India is ₹8,944.00 as on Feb 10, 2026.
What kind of stock is AstraZeneca Pharma India?
The AstraZeneca Pharma India is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of AstraZeneca Pharma India?
The market cap of AstraZeneca Pharma India is ₹22,360.00 Cr as on Feb 10, 2026.
What are today's High and Low prices of AstraZeneca Pharma India?
Today’s highest and lowest price of AstraZeneca Pharma India are ₹8,990.00 and ₹8,726.60.
What are the 52 Week High and 52 Week Low of AstraZeneca Pharma India?
The 52-week high/low is the highest and lowest price at which AstraZeneca Pharma India stock has traded in the past 52-week or nearly a year. The 52-week high of AstraZeneca Pharma India is ₹10,653.05 and 52-week low of AstraZeneca Pharma India is ₹6,501.60 as on Feb 10, 2026.
How has the AstraZeneca Pharma India performed historically in terms of returns?
The AstraZeneca Pharma India has shown returns of 3.09% over the past day, 8.78% for the past month, -1.57% over 3 months, 18.7% over 1 year, 38.36% across 3 years, and 19.28% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of AstraZeneca Pharma India?
P/E ratio of and PB ratio of AstraZeneca Pharma India are 112.28 and 27.98 on Feb 10, 2026. While the company gives a dividend yield of 0.36 per annum.
✕
Market Pulse